MV BioTherapeutics ApyraVax

Technology

The ApyraVax technology exploits the delivery of apyrase together with desired antigen/s.The innovative feature is the unique ability to generate high-affinity secretory IgA that are protective towards the target infectious agent.

MV BioTherapeutics ApyraVax